Hikma is an international pharmaceutical company conducting operations through three businesses: generic pharmaceuticals, branded pharmaceuticals and injectable pharmaceuticals. The company sells 113 branded and non-branded generic pharmaceutical products in 34 countries worldwide. The majority of Hikmas operations are in the United States, the Middle East and North Africa Region and Europe.
Registrars:
Key Personnel
CEO:
Riad Mishlawi
Non-Executive Director:
Ali Al-Husry
Executive Chairman:
Said Darwazah
Senior Independent Director:
Victoria Hull
Independent Non-Executive Director:
John J. Castellani, Laura Balan Balan, Mary (Nina) Henderson, Cynthia Schwalm, Deneen Vojta, Douglas Hurt